Clinical Trial Update: Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line [Phase 2]

View source ↗

Summary

Phase 2 trial investigating surufatinib with or without immunotherapy for advanced colorectal cancer in later-line settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Hubei Cancer Hospital | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN